Article
Familial Hypercholesterolemia: Update and Review.
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2022
Chacón-Camacho Oscar Francisco, Pozo-Molina Glustein, Méndez-Catalá Claudia Fabiola, Reyes-Reali Julia, Méndez-Cruz René, Zenteno Juan Carlos
Abstract excerpt
Knowledge of epidemiology, genetic etiopathogenesis, diagnostic criteria, and management of familial hypercholesterolemia have increased in the last two decades. Several population studies have shown that familial hypercholesterolemia is more frequent than previously thought, making this entity the most common metabolic disease with monogenic inheritance in the world. Identification of causal heterozygous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
